Koshinski Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-285
Closed -$49.1K 641
2022
Q1
$49.1K Buy
285
+32
+13% +$4.78K ﹤0.01% 1123
2021
Q4
$41K Buy
253
+62
+32% +$9.96K ﹤0.01% 1213
2021
Q3
$28.5K Buy
+191
New +$39.7K ﹤0.01% 1330

Other funds holding AMED

Koshinski Asset Management's AMED Position: Q2 2022 in Review

Koshinski Asset Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 285 shares — an estimated $49.1K sold.

Koshinski Asset Management first reported a position in AMED in Q3 2021 and held it in 3 quarters. The position peaked at $49.1K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Koshinski Asset Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 285 Amedisys shares in Q2 2022, an estimated $49.1K.
  • Koshinski Asset Management first reported a position in Amedisys in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Amedisys position peaked at $49.1K in Q1 2022.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.